Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes

Vulvovaginal candidiasis (VVC) is a common infection affecting women worldwide. Reports of patterns/risk factors/trends for episodic/recurrent VVC (RVVC) are largely outdated. The purpose of this study was to obtain current patient perspectives of several aspects of VVC/RVVC. Business cards containi...

Full description

Saved in:
Bibliographic Details
Published inBMC women's health Vol. 19; no. 1; pp. 48 - 9
Main Authors Yano, Junko, Sobel, Jack D., Nyirjesy, Paul, Sobel, Ryan, Williams, Valerie L., Yu, Qingzhao, Noverr, Mairi C., Fidel, Paul L.
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 29.03.2019
BioMed Central
BMC
Subjects
Adult
African Americans
Age
Analysis
Antibiotics
Antifungal agents
Antifungal Agents - therapeutic use
Birth control
Candidiasis
Candidiasis, Vulvovaginal - drug therapy
Candidiasis, Vulvovaginal - epidemiology
Candidiasis, Vulvovaginal - psychology
Care and treatment
Clinical outcomes
Cross-Sectional Studies
Diabetes
Disease management
Epidemiology
Female
Gynecology
Health Status
Heparan sulfate
Hormone replacement therapy
Humans
Incidence
Incidence rates
Infection
Infections
Internet
Itching
Laboratory tests
Medical research
Menstrual products
Middle Aged
Mycoses
Obstetrics
Pain
Patient outcomes
Patients
Pregnant women
Prevalence studies (Epidemiology)
Quality of Life
Questionnaires
Risk Factors
RVVC
Surveys and Questionnaires
Treatment Outcome
Trends
University students
Vaginitis
Vulvovaginal candidiasis
VVC
Weather
Women's health
Womens health
Young Adult
United States
Candida albicans
Vulvovaginal candidiasis
Incidence rates
Symptomatology
VVC
RVVC
Disease management
Vaginitis
Epidemiology
Risk factors
Online AccessGet full text

Cover

Abstract Vulvovaginal candidiasis (VVC) is a common infection affecting women worldwide. Reports of patterns/risk factors/trends for episodic/recurrent VVC (RVVC) are largely outdated. The purpose of this study was to obtain current patient perspectives of several aspects of VVC/RVVC. Business cards containing on-line survey information were distributed to healthy volunteers and patients seeking standard, elective, or referral gynecologic care in university-affiliated Obstetrics/Gynecology clinics. The internet-based questionnaire was completed by 284 non-pregnant women (78% Caucasian, 14% African American, 8% Asian). The majority of the participants (78%) indicated a history of VVC with 34% defined as having RVVC. The most common signs/symptoms experienced were itching, burning and redness with similar ranking of symptoms among VVC and RVVC patients. Among risk factors, antibiotic use ranked highest followed by intercourse, humid weather and use of feminine hygiene products. A high number of respondents noted 'no known cause' (idiopathic episodes) that was surprisingly similar among women with a history of either VVC or RVVC. VVC/RVVC episodes reported were primarily physician-diagnosed (73%) with the remainder mostly reporting self-diagnosis and treating with over-the-counter (OTC) medications. Most physician-diagnosed attacks utilized a combination of pelvic examination and laboratory tests followed by prescribed antifungals. Physician-treated cases achieved a higher level of symptom relief (84%) compared to those who self-medicated (57%). The majority of women with RVVC (71%) required continual or long-term antifungal medication as maintenance therapy to control symptoms. Current patient perspectives closely reflect historically documented estimates of VVC/RVVC prevalence and trends regarding symptomatology, disease management and post-treatment outcomes.
AbstractList Background Vulvovaginal candidiasis (VVC) is a common infection affecting women worldwide. Reports of patterns/risk factors/trends for episodic/recurrent VVC (RVVC) are largely outdated. The purpose of this study was to obtain current patient perspectives of several aspects of VVC/RVVC. Methods Business cards containing on-line survey information were distributed to healthy volunteers and patients seeking standard, elective, or referral gynecologic care in university-affiliated Obstetrics/Gynecology clinics. The internet-based questionnaire was completed by 284 non-pregnant women (78% Caucasian, 14% African American, 8% Asian). Results The majority of the participants (78%) indicated a history of VVC with 34% defined as having RVVC. The most common signs/symptoms experienced were itching, burning and redness with similar ranking of symptoms among VVC and RVVC patients. Among risk factors, antibiotic use ranked highest followed by intercourse, humid weather and use of feminine hygiene products. A high number of respondents noted ‘no known cause’ (idiopathic episodes) that was surprisingly similar among women with a history of either VVC or RVVC. VVC/RVVC episodes reported were primarily physician-diagnosed (73%) with the remainder mostly reporting self-diagnosis and treating with over-the-counter (OTC) medications. Most physician-diagnosed attacks utilized a combination of pelvic examination and laboratory tests followed by prescribed antifungals. Physician-treated cases achieved a higher level of symptom relief (84%) compared to those who self-medicated (57%). The majority of women with RVVC (71%) required continual or long-term antifungal medication as maintenance therapy to control symptoms. Conclusions Current patient perspectives closely reflect historically documented estimates of VVC/RVVC prevalence and trends regarding symptomatology, disease management and post-treatment outcomes.
Vulvovaginal candidiasis (VVC) is a common infection affecting women worldwide. Reports of patterns/risk factors/trends for episodic/recurrent VVC (RVVC) are largely outdated. The purpose of this study was to obtain current patient perspectives of several aspects of VVC/RVVC. Business cards containing on-line survey information were distributed to healthy volunteers and patients seeking standard, elective, or referral gynecologic care in university-affiliated Obstetrics/Gynecology clinics. The internet-based questionnaire was completed by 284 non-pregnant women (78% Caucasian, 14% African American, 8% Asian). The majority of the participants (78%) indicated a history of VVC with 34% defined as having RVVC. The most common signs/symptoms experienced were itching, burning and redness with similar ranking of symptoms among VVC and RVVC patients. Among risk factors, antibiotic use ranked highest followed by intercourse, humid weather and use of feminine hygiene products. A high number of respondents noted 'no known cause' (idiopathic episodes) that was surprisingly similar among women with a history of either VVC or RVVC. VVC/RVVC episodes reported were primarily physician-diagnosed (73%) with the remainder mostly reporting self-diagnosis and treating with over-the-counter (OTC) medications. Most physician-diagnosed attacks utilized a combination of pelvic examination and laboratory tests followed by prescribed antifungals. Physician-treated cases achieved a higher level of symptom relief (84%) compared to those who self-medicated (57%). The majority of women with RVVC (71%) required continual or long-term antifungal medication as maintenance therapy to control symptoms. Current patient perspectives closely reflect historically documented estimates of VVC/RVVC prevalence and trends regarding symptomatology, disease management and post-treatment outcomes.
Vulvovaginal candidiasis (VVC) is a common infection affecting women worldwide. Reports of patterns/risk factors/trends for episodic/recurrent VVC (RVVC) are largely outdated. The purpose of this study was to obtain current patient perspectives of several aspects of VVC/RVVC.BACKGROUNDVulvovaginal candidiasis (VVC) is a common infection affecting women worldwide. Reports of patterns/risk factors/trends for episodic/recurrent VVC (RVVC) are largely outdated. The purpose of this study was to obtain current patient perspectives of several aspects of VVC/RVVC.Business cards containing on-line survey information were distributed to healthy volunteers and patients seeking standard, elective, or referral gynecologic care in university-affiliated Obstetrics/Gynecology clinics. The internet-based questionnaire was completed by 284 non-pregnant women (78% Caucasian, 14% African American, 8% Asian).METHODSBusiness cards containing on-line survey information were distributed to healthy volunteers and patients seeking standard, elective, or referral gynecologic care in university-affiliated Obstetrics/Gynecology clinics. The internet-based questionnaire was completed by 284 non-pregnant women (78% Caucasian, 14% African American, 8% Asian).The majority of the participants (78%) indicated a history of VVC with 34% defined as having RVVC. The most common signs/symptoms experienced were itching, burning and redness with similar ranking of symptoms among VVC and RVVC patients. Among risk factors, antibiotic use ranked highest followed by intercourse, humid weather and use of feminine hygiene products. A high number of respondents noted 'no known cause' (idiopathic episodes) that was surprisingly similar among women with a history of either VVC or RVVC. VVC/RVVC episodes reported were primarily physician-diagnosed (73%) with the remainder mostly reporting self-diagnosis and treating with over-the-counter (OTC) medications. Most physician-diagnosed attacks utilized a combination of pelvic examination and laboratory tests followed by prescribed antifungals. Physician-treated cases achieved a higher level of symptom relief (84%) compared to those who self-medicated (57%). The majority of women with RVVC (71%) required continual or long-term antifungal medication as maintenance therapy to control symptoms.RESULTSThe majority of the participants (78%) indicated a history of VVC with 34% defined as having RVVC. The most common signs/symptoms experienced were itching, burning and redness with similar ranking of symptoms among VVC and RVVC patients. Among risk factors, antibiotic use ranked highest followed by intercourse, humid weather and use of feminine hygiene products. A high number of respondents noted 'no known cause' (idiopathic episodes) that was surprisingly similar among women with a history of either VVC or RVVC. VVC/RVVC episodes reported were primarily physician-diagnosed (73%) with the remainder mostly reporting self-diagnosis and treating with over-the-counter (OTC) medications. Most physician-diagnosed attacks utilized a combination of pelvic examination and laboratory tests followed by prescribed antifungals. Physician-treated cases achieved a higher level of symptom relief (84%) compared to those who self-medicated (57%). The majority of women with RVVC (71%) required continual or long-term antifungal medication as maintenance therapy to control symptoms.Current patient perspectives closely reflect historically documented estimates of VVC/RVVC prevalence and trends regarding symptomatology, disease management and post-treatment outcomes.CONCLUSIONSCurrent patient perspectives closely reflect historically documented estimates of VVC/RVVC prevalence and trends regarding symptomatology, disease management and post-treatment outcomes.
Abstract Background Vulvovaginal candidiasis (VVC) is a common infection affecting women worldwide. Reports of patterns/risk factors/trends for episodic/recurrent VVC (RVVC) are largely outdated. The purpose of this study was to obtain current patient perspectives of several aspects of VVC/RVVC. Methods Business cards containing on-line survey information were distributed to healthy volunteers and patients seeking standard, elective, or referral gynecologic care in university-affiliated Obstetrics/Gynecology clinics. The internet-based questionnaire was completed by 284 non-pregnant women (78% Caucasian, 14% African American, 8% Asian). Results The majority of the participants (78%) indicated a history of VVC with 34% defined as having RVVC. The most common signs/symptoms experienced were itching, burning and redness with similar ranking of symptoms among VVC and RVVC patients. Among risk factors, antibiotic use ranked highest followed by intercourse, humid weather and use of feminine hygiene products. A high number of respondents noted ‘no known cause’ (idiopathic episodes) that was surprisingly similar among women with a history of either VVC or RVVC. VVC/RVVC episodes reported were primarily physician-diagnosed (73%) with the remainder mostly reporting self-diagnosis and treating with over-the-counter (OTC) medications. Most physician-diagnosed attacks utilized a combination of pelvic examination and laboratory tests followed by prescribed antifungals. Physician-treated cases achieved a higher level of symptom relief (84%) compared to those who self-medicated (57%). The majority of women with RVVC (71%) required continual or long-term antifungal medication as maintenance therapy to control symptoms. Conclusions Current patient perspectives closely reflect historically documented estimates of VVC/RVVC prevalence and trends regarding symptomatology, disease management and post-treatment outcomes.
Background Vulvovaginal candidiasis (VVC) is a common infection affecting women worldwide. Reports of patterns/risk factors/trends for episodic/recurrent VVC (RVVC) are largely outdated. The purpose of this study was to obtain current patient perspectives of several aspects of VVC/RVVC. Methods Business cards containing on-line survey information were distributed to healthy volunteers and patients seeking standard, elective, or referral gynecologic care in university-affiliated Obstetrics/Gynecology clinics. The internet-based questionnaire was completed by 284 non-pregnant women (78% Caucasian, 14% African American, 8% Asian). Results The majority of the participants (78%) indicated a history of VVC with 34% defined as having RVVC. The most common signs/symptoms experienced were itching, burning and redness with similar ranking of symptoms among VVC and RVVC patients. Among risk factors, antibiotic use ranked highest followed by intercourse, humid weather and use of feminine hygiene products. A high number of respondents noted 'no known cause' (idiopathic episodes) that was surprisingly similar among women with a history of either VVC or RVVC. VVC/RVVC episodes reported were primarily physician-diagnosed (73%) with the remainder mostly reporting self-diagnosis and treating with over-the-counter (OTC) medications. Most physician-diagnosed attacks utilized a combination of pelvic examination and laboratory tests followed by prescribed antifungals. Physician-treated cases achieved a higher level of symptom relief (84%) compared to those who self-medicated (57%). The majority of women with RVVC (71%) required continual or long-term antifungal medication as maintenance therapy to control symptoms. Conclusions Current patient perspectives closely reflect historically documented estimates of VVC/RVVC prevalence and trends regarding symptomatology, disease management and post-treatment outcomes. Keywords: Vaginitis, Vulvovaginal candidiasis, VVC, RVVC, Epidemiology, Incidence rates, Candida albicans, Symptomatology, Risk factors, Disease management
Vulvovaginal candidiasis (VVC) is a common infection affecting women worldwide. Reports of patterns/risk factors/trends for episodic/recurrent VVC (RVVC) are largely outdated. The purpose of this study was to obtain current patient perspectives of several aspects of VVC/RVVC. Business cards containing on-line survey information were distributed to healthy volunteers and patients seeking standard, elective, or referral gynecologic care in university-affiliated Obstetrics/Gynecology clinics. The internet-based questionnaire was completed by 284 non-pregnant women (78% Caucasian, 14% African American, 8% Asian). The majority of the participants (78%) indicated a history of VVC with 34% defined as having RVVC. The most common signs/symptoms experienced were itching, burning and redness with similar ranking of symptoms among VVC and RVVC patients. Among risk factors, antibiotic use ranked highest followed by intercourse, humid weather and use of feminine hygiene products. A high number of respondents noted 'no known cause' (idiopathic episodes) that was surprisingly similar among women with a history of either VVC or RVVC. VVC/RVVC episodes reported were primarily physician-diagnosed (73%) with the remainder mostly reporting self-diagnosis and treating with over-the-counter (OTC) medications. Most physician-diagnosed attacks utilized a combination of pelvic examination and laboratory tests followed by prescribed antifungals. Physician-treated cases achieved a higher level of symptom relief (84%) compared to those who self-medicated (57%). The majority of women with RVVC (71%) required continual or long-term antifungal medication as maintenance therapy to control symptoms. Current patient perspectives closely reflect historically documented estimates of VVC/RVVC prevalence and trends regarding symptomatology, disease management and post-treatment outcomes.
ArticleNumber 48
Audience Academic
Author Yu, Qingzhao
Sobel, Ryan
Nyirjesy, Paul
Sobel, Jack D.
Williams, Valerie L.
Yano, Junko
Noverr, Mairi C.
Fidel, Paul L.
Author_xml – sequence: 1
  givenname: Junko
  surname: Yano
  fullname: Yano, Junko
– sequence: 2
  givenname: Jack D.
  surname: Sobel
  fullname: Sobel, Jack D.
– sequence: 3
  givenname: Paul
  surname: Nyirjesy
  fullname: Nyirjesy, Paul
– sequence: 4
  givenname: Ryan
  surname: Sobel
  fullname: Sobel, Ryan
– sequence: 5
  givenname: Valerie L.
  surname: Williams
  fullname: Williams, Valerie L.
– sequence: 6
  givenname: Qingzhao
  surname: Yu
  fullname: Yu, Qingzhao
– sequence: 7
  givenname: Mairi C.
  surname: Noverr
  fullname: Noverr, Mairi C.
– sequence: 8
  givenname: Paul L.
  orcidid: 0000-0001-8066-5763
  surname: Fidel
  fullname: Fidel, Paul L.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30925872$$D View this record in MEDLINE/PubMed
BookMark eNp9kktr3DAURk1JaR7tD-imGLrpIk71siR3UQhDH4FAN-1ayHq4GmzJleSB_PvKM2maCaUYLHF97hHX-s6rEx-8qarXEFxByOn7BFEH2gbArgGM8IY_q84gYaihnJGTR_vT6jylLQCQ8Za9qE4x6FDLGTqrls0So_G5nmV2-9XENBuV3c6kOth6t4y7sJOD83KslfTaaSeTSx9q55XTxitzWae7ac5hSpf1JL0czLSaClvPIeUmRyPzvhSWrMJk0svquZVjMq_u14vqx-dP3zdfm9tvX24217eNainIjcayw1pRqHoLKNeESI37FkmmFbe2VYhihSBG2OIOMUKYMhZK2CJIy7vHF9XNwauD3Io5uknGOxGkE_tCiIOQMTs1GmERJbbtTatVTziVvWJGdR3QvdaYMFhcHw-ueekno1WZJ8rxSHr8xbufYgg7QQmBkJEieHcviOHXYlIWk0vKjKP0JixJIARAuR9IQUHfPkG3YYnlBlYKQkQYoPgvNcgygPM2lHPVKhXXLYe4HEtW19U_qPJoMzlVAmVdqR81vHk86MOEf0JTAHgAVAwpRWMfEAjEGkxxCKYowRRrMAUvPexJj3K5RC6s_8qN_-n8Dapc6NU
CitedBy_id crossref_primary_10_3389_fmolb_2021_656844
crossref_primary_10_1128_IAI_00624_20
crossref_primary_10_1128_spectrum_00161_23
crossref_primary_10_1016_j_carbpol_2022_120420
crossref_primary_10_1186_s12905_023_02253_y
crossref_primary_10_3390_microorganisms8010034
crossref_primary_10_3390_molecules28217377
crossref_primary_10_1016_j_bcab_2019_101195
crossref_primary_10_1016_j_jep_2022_116041
crossref_primary_10_1007_s00129_024_05317_8
crossref_primary_10_1038_s41598_024_59869_9
crossref_primary_10_1080_13543784_2020_1791820
crossref_primary_10_1007_s42452_024_05628_4
crossref_primary_10_1007_s00129_020_04664_6
crossref_primary_10_22207_JPAM_18_1_20
crossref_primary_10_1007_s11046_022_00687_w
crossref_primary_10_1093_mmy_myab034
crossref_primary_10_1038_s41564_021_00875_2
crossref_primary_10_1016_j_ogc_2022_07_004
crossref_primary_10_3390_jof6030113
crossref_primary_10_1007_s11046_021_00592_8
crossref_primary_10_1186_s12906_021_03405_z
crossref_primary_10_33631_sabd_1359836
crossref_primary_10_1093_mmy_myac080
crossref_primary_10_25259_JLP_2023_8_4__1747
crossref_primary_10_1016_j_jtcms_2024_11_002
crossref_primary_10_1016_j_carbpol_2021_117919
crossref_primary_10_1128_aac_00778_23
crossref_primary_10_3389_fimmu_2022_1066383
crossref_primary_10_3389_fitd_2022_890296
crossref_primary_10_1093_cid_ciaa260
crossref_primary_10_3390_pathogens10121576
crossref_primary_10_1371_journal_pone_0269590
crossref_primary_10_1002_bdr2_2308
crossref_primary_10_1128_mbio_03409_23
crossref_primary_10_3390_jof6030183
crossref_primary_10_3389_fmicb_2020_544480
crossref_primary_10_1128_iai_00350_23
crossref_primary_10_1186_s12884_025_07402_9
crossref_primary_10_3389_fimmu_2020_612269
crossref_primary_10_1111_1471_0528_16972
crossref_primary_10_1007_s40588_023_00190_w
crossref_primary_10_1007_s42770_024_01602_9
crossref_primary_10_1093_femsre_fuaa060
crossref_primary_10_1186_s12889_024_17668_x
crossref_primary_10_3390_biomedicines12020389
crossref_primary_10_1007_s11908_020_0712_7
crossref_primary_10_1111_myc_13248
crossref_primary_10_1186_s12905_025_03616_3
crossref_primary_10_3390_jof6040267
crossref_primary_10_1007_s10103_025_04283_4
crossref_primary_10_1038_s41598_021_92605_1
crossref_primary_10_1097_OLQ_0000000000001066
crossref_primary_10_3389_fmicb_2022_787119
crossref_primary_10_2217_nnm_2022_0323
crossref_primary_10_1016_j_crmicr_2024_100255
crossref_primary_10_17116_klinderma202019061855
crossref_primary_10_1007_s40588_021_00169_5
crossref_primary_10_1371_journal_pone_0249925
crossref_primary_10_3390_life13040924
crossref_primary_10_3390_tropicalmed9050114
crossref_primary_10_1007_s11046_021_00556_y
crossref_primary_10_1186_s40779_019_0226_5
crossref_primary_10_3390_pathogens9060489
crossref_primary_10_1016_j_fander_2021_05_002
crossref_primary_10_1111_aji_70040
crossref_primary_10_1016_j_heliyon_2024_e27239
crossref_primary_10_2147_IDR_S226154
crossref_primary_10_3390_app14072676
crossref_primary_10_1038_s41577_022_00826_w
crossref_primary_10_1128_msystems_01066_21
crossref_primary_10_3390_pathogens10121546
crossref_primary_10_3390_ijms21176131
crossref_primary_10_1007_s12010_022_03813_y
crossref_primary_10_1080_21505594_2021_2019950
crossref_primary_10_3389_fmicb_2021_692491
crossref_primary_10_1002_wsbm_1641
crossref_primary_10_1371_journal_pone_0267866
crossref_primary_10_2478_amb_2023_0039
crossref_primary_10_1155_2022_1739729
crossref_primary_10_1016_j_genrep_2021_101463
crossref_primary_10_1111_jog_15267
crossref_primary_10_1208_s12249_024_02914_7
crossref_primary_10_1128_spectrum_02724_21
crossref_primary_10_3389_fcimb_2022_838405
crossref_primary_10_3389_frph_2022_915948
crossref_primary_10_1093_oxfimm_iqae010
crossref_primary_10_1093_infdis_jiaf028
crossref_primary_10_1021_acsinfecdis_1c00270
crossref_primary_10_1055_a_1345_8793
crossref_primary_10_3390_jcm12165376
crossref_primary_10_1155_2021_4948954
crossref_primary_10_1186_s40001_022_00938_y
crossref_primary_10_1016_j_mycmed_2024_101516
crossref_primary_10_1093_jambio_lxae269
crossref_primary_10_1080_01932691_2022_2158854
crossref_primary_10_1016_j_tcsw_2024_100128
crossref_primary_10_62610_RJOR_2024_3_16_67
crossref_primary_10_1055_s_0042_1758858
crossref_primary_10_1080_21505594_2025_2451165
crossref_primary_10_1186_s43094_023_00533_w
crossref_primary_10_1016_j_ejps_2023_106508
crossref_primary_10_1097_JXX_0000000000000534
crossref_primary_10_1136_gocm_2024_000014
crossref_primary_10_1038_s41585_021_00562_1
crossref_primary_10_1007_s40199_024_00546_7
crossref_primary_10_1177_20503121221115201
crossref_primary_10_3389_fmicb_2021_739385
crossref_primary_10_1016_j_tcsw_2022_100084
crossref_primary_10_1016_j_tim_2019_07_006
crossref_primary_10_3390_jof6010035
crossref_primary_10_1016_j_ctim_2020_102483
crossref_primary_10_3389_fmolb_2021_702370
crossref_primary_10_1038_s41598_024_63149_x
crossref_primary_10_1016_j_ogc_2023_02_005
crossref_primary_10_1111_myc_13602
crossref_primary_10_1177_20503121221085437
crossref_primary_10_1007_s11046_024_00904_8
crossref_primary_10_22207_JPAM_18_1_01
crossref_primary_10_1002_cbdv_202402339
crossref_primary_10_1016_j_smim_2023_101752
crossref_primary_10_3389_fcimb_2022_934353
crossref_primary_10_1089_tmj_2022_0218
crossref_primary_10_1007_s00404_020_05784_z
crossref_primary_10_3389_fphar_2025_1484325
crossref_primary_10_3390_medicina59112004
crossref_primary_10_1002_mba2_100
crossref_primary_10_1016_j_micinf_2023_105232
crossref_primary_10_1016_j_pec_2023_108004
crossref_primary_10_1186_s12905_022_01973_x
crossref_primary_10_3390_gels9120949
crossref_primary_10_1016_j_bioflm_2023_100162
crossref_primary_10_62610_RJOR_2024_1_16_57
crossref_primary_10_1128_AAC_01777_19
crossref_primary_10_1080_08927014_2023_2256674
crossref_primary_10_3390_jof8010020
crossref_primary_10_1371_journal_ppat_1012018
crossref_primary_10_3389_fmicb_2022_998849
crossref_primary_10_3390_ijms25073796
crossref_primary_10_17116_klinderma202423041377
crossref_primary_10_3389_fcimb_2023_1113401
crossref_primary_10_1016_j_yfpn_2021_12_006
crossref_primary_10_3390_pathogens12060756
crossref_primary_10_70360_rccse__v_148
crossref_primary_10_1007_s10096_021_04199_1
crossref_primary_10_1007_s12281_019_00357_3
crossref_primary_10_1016_j_micpath_2021_104825
crossref_primary_10_22207_JPAM_18_4_05
crossref_primary_10_3390_jof8050495
crossref_primary_10_22207_JPAM_15_1_14
crossref_primary_10_3390_pharmaceutics16030312
crossref_primary_10_1080_19490976_2023_2287618
Cites_doi 10.1016/j.tim.2004.03.006
10.1056/NEJMoa033114
10.1097/00001648-199603000-00013
10.1016/S0140-6736(07)60917-9
10.1097/LGT.0b013e318273e8cf
10.1371/journal.ppat.1003965
10.1128/mBio.00211-17
10.1089/jwh.1998.7.1167
10.1093/clinids/14.Supplement_1.S148
10.1128/CMR.00076-09
10.1097/00007435-200004000-00009
10.1126/scitranslmed.3002613
10.1093/clinids/20.Supplement_1.S80
10.1111/1471-0528.12994
10.1001/jama.1984.03340290034016
10.2105/AJPH.85.8_Pt_1.1146
10.1016/S1473-3099(18)30103-8
10.1056/NEJM199712253372607
10.1016/S0002-9378(98)80001-X
10.1067/mob.2001.115116
10.1371/journal.pone.0054379
10.1128/IAI.72.5.2939-2946.2004
10.1186/1471-2334-2-1
10.1016/j.annepidem.2017.08.010
10.1097/LGT.0b013e3182241f1a
10.1001/jama.291.11.1368
10.1016/j.cyto.2011.11.021
10.1016/S0002-9378(85)80003-X
10.1136/pgmj.55.647.645
ContentType Journal Article
Copyright COPYRIGHT 2019 BioMed Central Ltd.
2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s). 2019
Copyright_xml – notice: COPYRIGHT 2019 BioMed Central Ltd.
– notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s). 2019
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7R6
7RV
7X7
7XB
888
88E
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
KB0
M0S
M1P
NAPCQ
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PMKZF
PPXIY
PQEST
PQGEN
PQQKQ
PQUKI
PSYQQ
QXPDG
7X8
5PM
DOA
DOI 10.1186/s12905-019-0748-8
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
GenderWatch
Nursing & allied health premium.
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
GenderWatch (Alumni Edition)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability (subscription)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Medical Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
ProQuest Publicly Available Content
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest Digital Collections
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Women's Studies
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest One Psychology
Diversity Collection
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Open Access Full Text
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Psychology
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central
ProQuest One Sustainability
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Diversity Collection
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
GenderWatch (Alumni Edition)
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Digital Collections
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
GenderWatch
ProQuest One Academic UKI Edition
ProQuest Women's & Gender Studies
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database

MEDLINE - Academic


MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 1472-6874
EndPage 9
ExternalDocumentID oai_doaj_org_article_f264f5be5dcb486abc7ec990dbdd3471
PMC6441174
A581341140
30925872
10_1186_s12905_019_0748_8
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations United States
GeographicLocations_xml – name: United States
GrantInformation_xml – fundername: NIGMS NIH HHS
  grantid: U54 GM104940
– fundername: ;
– fundername: ;
  grantid: U54 GM104940
GroupedDBID ---
04C
0R~
23N
2WC
53G
5VS
6J9
6PF
7R6
7RV
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACHQT
ACIHN
ACUHS
ADBBV
ADOJX
ADRAZ
ADUKV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BKEYQ
BMC
BMSDO
BPHCQ
BVXVI
C6C
CCPQU
CITATION
DIK
DU5
E3Z
EBD
EBLON
EBS
ECF
ECT
EIHBH
EJD
ESX
EX3
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
ICW
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PMKZF
PQQKQ
PROAC
PSQYO
PSYQQ
QXPDG
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
~8M
-5E
-5G
-A0
-BR
3V.
ACRMQ
ADINQ
C24
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGEN
PQUKI
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c560t-d3a93dc61cbf068d44ad3b52a7dc8ff5c263c21323f3927447cef1a15216a15b3
IEDL.DBID M48
ISSN 1472-6874
IngestDate Wed Aug 27 01:29:09 EDT 2025
Thu Aug 21 14:10:32 EDT 2025
Fri Jul 11 10:03:44 EDT 2025
Sat Jul 26 00:11:09 EDT 2025
Tue Jun 17 21:07:31 EDT 2025
Tue Jun 10 20:20:04 EDT 2025
Thu Jan 02 22:58:53 EST 2025
Tue Jul 01 00:26:18 EDT 2025
Thu Apr 24 23:02:27 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Candida albicans
Vulvovaginal candidiasis
Incidence rates
Symptomatology
VVC
RVVC
Disease management
Vaginitis
Epidemiology
Risk factors
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c560t-d3a93dc61cbf068d44ad3b52a7dc8ff5c263c21323f3927447cef1a15216a15b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-8066-5763
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12905-019-0748-8
PMID 30925872
PQID 2211247063
PQPubID 42554
PageCount 9
ParticipantIDs doaj_primary_oai_doaj_org_article_f264f5be5dcb486abc7ec990dbdd3471
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6441174
proquest_miscellaneous_2200785160
proquest_journals_2211247063
gale_infotracmisc_A581341140
gale_infotracacademiconefile_A581341140
pubmed_primary_30925872
crossref_primary_10_1186_s12905_019_0748_8
crossref_citationtrail_10_1186_s12905_019_0748_8
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-03-29
PublicationDateYYYYMMDD 2019-03-29
PublicationDate_xml – month: 03
  year: 2019
  text: 2019-03-29
  day: 29
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC women's health
PublicationTitleAlternate BMC Womens Health
PublicationYear 2019
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References JD Mintz (748_CR32) 2013; 3
PL Fidel Jr (748_CR10) 2004; 12
JD Sobel (748_CR5) 1997; 337
T Drell (748_CR29) 2013; 8
DW Denning (748_CR7) 2018; 18
BM Peters (748_CR11) 2014; 10
A Cassone (748_CR13) 2015; 122
PL Fidel Jr (748_CR3) 2004; 72
AO Berg (748_CR17) 1984; 251
F Blostein (748_CR8) 2017; 27
JD Sobel (748_CR1) 1985; 152
G Fischer (748_CR21) 2011; 15
AM Geiger (748_CR27) 1996; 7
AM Geiger (748_CR31) 1995; 71
B Foxman (748_CR26) 2013; 17
J Yano (748_CR12) 2012; 58
JD Sobel (748_CR2) 1998; 178
J Yano (748_CR14) 2017; 8
AM Geiger (748_CR16) 1995; 85
B Foxman (748_CR20) 1998; 7
EM de Leon (748_CR28) 2002; 2
JD Sobel (748_CR24) 2004; 351
BJ Horowitz (748_CR18) 1987; 69
JD Sobel (748_CR4) 1992; 14
R Hurley (748_CR15) 1979; 55
SE Reef (748_CR23) 1995; 20
JM Achkar (748_CR6) 2010; 23
JD Sobel (748_CR9) 2007; 369
B Foxman (748_CR30) 2000; 27
JD Sobel (748_CR22) 2001; 185
MA Farmer (748_CR25) 2011; 3
MR Anderson (748_CR19) 2004; 291
References_xml – volume: 12
  start-page: 220
  issue: 5
  year: 2004
  ident: 748_CR10
  publication-title: Trends Microbiol
  doi: 10.1016/j.tim.2004.03.006
– volume: 351
  start-page: 876
  issue: 9
  year: 2004
  ident: 748_CR24
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa033114
– volume: 7
  start-page: 182
  issue: 2
  year: 1996
  ident: 748_CR27
  publication-title: Epidemiology.
  doi: 10.1097/00001648-199603000-00013
– volume: 369
  start-page: 1961
  issue: 9577
  year: 2007
  ident: 748_CR9
  publication-title: Lancet.
  doi: 10.1016/S0140-6736(07)60917-9
– volume: 17
  start-page: 340
  issue: 3
  year: 2013
  ident: 748_CR26
  publication-title: J Low Genit Tract Dis
  doi: 10.1097/LGT.0b013e318273e8cf
– volume: 10
  issue: 4
  year: 2014
  ident: 748_CR11
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1003965
– volume: 8
  start-page: e00211
  issue: 2
  year: 2017
  ident: 748_CR14
  publication-title: mBio
  doi: 10.1128/mBio.00211-17
– volume: 7
  start-page: 1167
  issue: 9
  year: 1998
  ident: 748_CR20
  publication-title: J Women's Health
  doi: 10.1089/jwh.1998.7.1167
– volume: 14
  start-page: S148
  issue: Suppl 1
  year: 1992
  ident: 748_CR4
  publication-title: Clin Infect Dis
  doi: 10.1093/clinids/14.Supplement_1.S148
– volume: 23
  start-page: 253
  issue: 2
  year: 2010
  ident: 748_CR6
  publication-title: Clin Microbiol Rev
  doi: 10.1128/CMR.00076-09
– volume: 27
  start-page: 230
  issue: 4
  year: 2000
  ident: 748_CR30
  publication-title: Sex Transm Dis
  doi: 10.1097/00007435-200004000-00009
– volume: 3
  start-page: 101ra91
  issue: 101
  year: 2011
  ident: 748_CR25
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.3002613
– volume: 20
  start-page: S80
  issue: Suppl 1
  year: 1995
  ident: 748_CR23
  publication-title: Clin Infect Dis
  doi: 10.1093/clinids/20.Supplement_1.S80
– volume: 122
  start-page: 785
  issue: 6
  year: 2015
  ident: 748_CR13
  publication-title: BJOG.
  doi: 10.1111/1471-0528.12994
– volume: 251
  start-page: 620
  issue: 5
  year: 1984
  ident: 748_CR17
  publication-title: JAMA
  doi: 10.1001/jama.1984.03340290034016
– volume: 85
  start-page: 1146
  issue: 8 Pt 1
  year: 1995
  ident: 748_CR16
  publication-title: Am J Public Health
  doi: 10.2105/AJPH.85.8_Pt_1.1146
– volume: 69
  start-page: 883
  issue: 6
  year: 1987
  ident: 748_CR18
  publication-title: Obstet Gynecol
– volume: 18
  start-page: e339
  issue: 11
  year: 2018
  ident: 748_CR7
  publication-title: Lancet Infect Dis
  doi: 10.1016/S1473-3099(18)30103-8
– volume: 337
  start-page: 1896
  issue: 26
  year: 1997
  ident: 748_CR5
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199712253372607
– volume: 178
  start-page: 203
  issue: 2
  year: 1998
  ident: 748_CR2
  publication-title: Am J Obstet Gynecol
  doi: 10.1016/S0002-9378(98)80001-X
– volume: 185
  start-page: 363
  issue: 2
  year: 2001
  ident: 748_CR22
  publication-title: Am J Obstet Gynecol
  doi: 10.1067/mob.2001.115116
– volume: 8
  issue: 1
  year: 2013
  ident: 748_CR29
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0054379
– volume: 72
  start-page: 2939
  year: 2004
  ident: 748_CR3
  publication-title: Infect Immun
  doi: 10.1128/IAI.72.5.2939-2946.2004
– volume: 2
  start-page: 1
  year: 2002
  ident: 748_CR28
  publication-title: BMC Infect Dis
  doi: 10.1186/1471-2334-2-1
– volume: 27
  start-page: 575
  issue: 9
  year: 2017
  ident: 748_CR8
  publication-title: Ann Epidemiol
  doi: 10.1016/j.annepidem.2017.08.010
– volume: 15
  start-page: 263
  issue: 4
  year: 2011
  ident: 748_CR21
  publication-title: J Low Genit Tract Dis
  doi: 10.1097/LGT.0b013e3182241f1a
– volume: 291
  start-page: 1368
  issue: 11
  year: 2004
  ident: 748_CR19
  publication-title: JAMA.
  doi: 10.1001/jama.291.11.1368
– volume: 58
  start-page: 118
  issue: 1
  year: 2012
  ident: 748_CR12
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2011.11.021
– volume: 71
  start-page: 304
  issue: 5
  year: 1995
  ident: 748_CR31
  publication-title: Genitourin Med
– volume: 152
  start-page: 924
  issue: 7
  year: 1985
  ident: 748_CR1
  publication-title: Am J Obstet Gynecol
  doi: 10.1016/S0002-9378(85)80003-X
– volume: 55
  start-page: 645
  issue: 647
  year: 1979
  ident: 748_CR15
  publication-title: Postgrad Med J
  doi: 10.1136/pgmj.55.647.645
– volume: 3
  start-page: 5
  issue: 4
  year: 2013
  ident: 748_CR32
  publication-title: Adv Infect Dis
SSID ssj0017857
Score 2.5456634
Snippet Vulvovaginal candidiasis (VVC) is a common infection affecting women worldwide. Reports of patterns/risk factors/trends for episodic/recurrent VVC (RVVC) are...
Background Vulvovaginal candidiasis (VVC) is a common infection affecting women worldwide. Reports of patterns/risk factors/trends for episodic/recurrent VVC...
Abstract Background Vulvovaginal candidiasis (VVC) is a common infection affecting women worldwide. Reports of patterns/risk factors/trends for...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 48
SubjectTerms Adult
African Americans
Age
Analysis
Antibiotics
Antifungal agents
Antifungal Agents - therapeutic use
Birth control
Candidiasis
Candidiasis, Vulvovaginal - drug therapy
Candidiasis, Vulvovaginal - epidemiology
Candidiasis, Vulvovaginal - psychology
Care and treatment
Clinical outcomes
Cross-Sectional Studies
Diabetes
Disease management
Epidemiology
Female
Gynecology
Health Status
Heparan sulfate
Hormone replacement therapy
Humans
Incidence
Incidence rates
Infection
Infections
Internet
Itching
Laboratory tests
Medical research
Menstrual products
Middle Aged
Mycoses
Obstetrics
Pain
Patient outcomes
Patients
Pregnant women
Prevalence studies (Epidemiology)
Quality of Life
Questionnaires
Risk Factors
RVVC
Surveys and Questionnaires
Treatment Outcome
Trends
University students
Vaginitis
Vulvovaginal candidiasis
VVC
Weather
Women's health
Womens health
Young Adult
SummonAdditionalLinks – databaseName: DOAJ Open Access Full Text
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9UwEA-yJ0HEb6urRBAE2bJtPprU2youi6AnF_YWkjTBhX3tY9s-8L93Ju2rrwh68dJDMylNZpKZSWZ-Q8hb4byoLab9OlfgaRXPXRls3tS1YFFLWyRQn6_fqotL8eVKXh2U-sKYsAkeeJq40wgaO0oXZOOd0JV1XgUPW2jjmoaLlD3OQOftnan5_kBpqeY7zFJXpz2etmCQGibsCJ3rlRZKYP1_bskHOmkdL3mggM4fkPuz5UjPpj9-SO6E9hG5Nx270Smb6DEZZ7wlOuOl0u3vZMqedpHuxptdt7OpGBb1mNMCAtJf9x8oHrqnAqMntP-52Q7dpj-hmyU6hgIt3Xb9kC-x6bQbBxDY0D8hl-efv3-6yOfKCrkHC2fIG25r3viq9C4WlW6EsA13klnVeB2j9KzinoGjyiPYT0oI5UMsLer6Cp6OPyVHbdeG54SC_RYCszqUXAkphBMVd85JrjwPMrKMFPuZNn6GHcfqFzcmuR-6MhNzDDDHIHOMzsj7pct2wtz4G_FHZN9CiHDZ6QUIkZmFyPxLiDLyDplvcFHDz3k75ybAEBEey5xJjcB34Ixm5HhFCYvRr5v34mPmzaA3DJxsJhQYgxl5szRjTwxwa0M3Ig0aa7Ks4BPPJmlbhsSLmkmtYCrVSg5XY163tNc_ElQ4Wrvgc774H5P0ktxlaQVh8b9jcjTcjuEVWGSDe50W3y9uVzYs
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Na9VAEF-0XgQRvxtbZQVBkIa-ZHezGy9SxVIEPVl4t2W_ooW-JDbJA__7ziT70gahlxyyk5Ddmd35yMxvCHnPreOlwbJfa1cYrWKpzYJJfVnyvFLCrEZQnx8_i7Nz_n0t1jHg1sW0yt2ZOB7UvnEYIz_OwVPJuQSN-rn9m2LXKPy7Glto3CcPELoMU7rkena4sPG8jH8yM1UcdxhzwVQ1LNvhKlULXTRC9v9_MN_STMusyVtq6PQJeRztR3oyMfwpuRfqZ-TRFHyjU03RczJE1CUaUVNpe1NS2dGmotvhcttszdgSizqsbAEx6S66TxRD72Ob0SPa_du0fbPpjuhmzpGhQEvbpuvTOUOdNkMPSxi6F-T89Nuvr2dp7K-QOrBz-tQzUzLviszZalUoz7nxzIrcSO9UVQmXF8zl4K6yCqwoybl0ocoMavwCrpa9JHt1U4d9QsGKCyE3KmRMcsG55QWz1gomHQuiyhOy2q20dhF8HHtgXOrRCVGFnpijgTkamaNVQj7Oj7QT8sZdxF-QfTMhgmaPN5qr3zruQV2B8VcJG4R3lqvCWCeDA23srfcMlHRCPiDzNW5t-DhnYoUCTBFBsvSJUAh_By5pQg4XlLAl3XJ4Jz46HgmdvhHghLybh_FJTHOrQzMgDZpsIivgFa8maZunxFZlLpSEpZQLOVzMeTlSX_wZAcPR5gXP8_Xdn3VAHubj3sDmfodkr78awhuwuHr7dtxW19B5K-8
  priority: 102
  providerName: ProQuest
Title Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes
URI https://www.ncbi.nlm.nih.gov/pubmed/30925872
https://www.proquest.com/docview/2211247063
https://www.proquest.com/docview/2200785160
https://pubmed.ncbi.nlm.nih.gov/PMC6441174
https://doaj.org/article/f264f5be5dcb486abc7ec990dbdd3471
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ra9swEBd9wCiUsXe9dUGDwWDUW6KHpQzGaEZLGbSMskDYF2HJ8lZI4ix2wvrf70523JqVfdgXf4hOxvLd5X53vgchr4V1Yphi2a-1fYxW8dgOfBpnw6FguZZpPzT1Ob9Izsbiy0ROtshmvFXzAss7XTucJzVeTt_9_nX9CRT-Y1B4nbwvMZaCKWhYjiN0rLfJLhgmhXp6Lm4-KigtVfNh885te-Qe7w-Z1Ip1rFRo5v_3X_Ytm9XNp7xloE4fkPsNsqTHtSg8JFt-_ojs12E5WlcbPSarph8Tbfqp0sVNsWVJi5yuV9N1sU7DsCzqsOYFBKi8Kj9QDMqHAaRHtLyeLapiVh7RWZs9Q4GWLoqyitvcdVqsKhBoXz4h49OTb5_P4mbyQuwAAVVxxtMhz1wycDbvJzoTIs24lSxVmdN5Lh1LuGPgyPIc8JUSQjmfD1LEAglcLX9KdubF3B8QCvjOe5ZqP-BKSCGsSLi1VnLluJc5i0h_86aNa9qS43SMqQnuiU5MzScDfDLIJ6Mj8rbdsqh7cvyLeITsawmxnXb4oVj-MI12mhxgYS6tl5mzQiepdco7sNOZzTIO5jsib5D5BsUQHs6lTe0CHBHbZ5ljqbExHjirETnsUIKyuu7yRnzMRtYNAyecCQVgMSKv2mXciQlwc1-skAbBnBwkcItntbS1R9oIbURURw47Z-6uzK9-hlbiiIbBJ33-3ztfkD0WNAgnAh6SnWq58i8BplW2R7bVRPXI7ujk4utlLwQ7ekEh4Xo5-v4HVEVA4A
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3batRAdKjbBwUR765WHUERpKGbuSSzgkirLVvbLiIt9G06t2ihu1mb7Ep_ym_0nCSbNgh968s-7JyEzJz7mXMh5K2wTgwNlv1aO8BoFY9sHEzkh0PBMiXNoGrqczBORkfi27E8XiF_l7UwmFa5lImVoPa5wxj5BgNPhYkUNOrn2e8Ip0bh7epyhEZNFnvh4g-4bMWn3a-A33eM7WwffhlFzVSByIF2LyPPzZB7l8TOZoNEeSGM51Yyk3qnskw6lnDHwEnjGdgOqRCpC1lsUM8l8Gs5vPcWWRUcXJkeWd3aHn__0d5bpEqmzd1prJKNAqM8mByHhUJCRaqj_aohAf-rgiu6sJuneUXx7dwn9xqLlW7WJPaArITpQ3K3DvfRuorpEZk3fZ5o06eVzi6LOAuaZ3QxP1vkC1MN4aIOa2mAMIvT4iPFYH812HSdFheTWZlPinU6abNyKMDSWV6UUZsTT_N5CUgLxWNydCNn_4T0pvk0PCMU7MYQmFEh5qmQQliRcGut5KnjQWasTwbLk9auaXeOUzfOdOX2qETXyNGAHI3I0apPPrSPzOpeH9cBbyH6WkBs0139kZ__1A3X6wzMzUzaIL2zQiXGujQ40P_ees_BLOiT94h8jcIEPs6ZpiYCtohtufSmVNhwD5zgPlnrQIIQcN3lJfnoRggV-pJl-uRNu4xPYmLdNORzhEEjUcYJvOJpTW3tlvhgyKRK4SjTDh129txdmZ7-qlqUo5UNvu7z6z_rNbk9OjzY1_u7470X5A6r-ARHC66RXnk-Dy_B3ivtq4bJKDm5ab7-B5KyaiQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Current+patient+perspectives+of+vulvovaginal+candidiasis%3A+incidence%2C+symptoms%2C+management+and+post-treatment+outcomes&rft.jtitle=BMC+women%27s+health&rft.au=Yano%2C+Junko&rft.au=Sobel%2C+Jack+D.&rft.au=Nyirjesy%2C+Paul&rft.au=Sobel%2C+Ryan&rft.date=2019-03-29&rft.pub=BioMed+Central&rft.eissn=1472-6874&rft.volume=19&rft_id=info:doi/10.1186%2Fs12905-019-0748-8&rft_id=info%3Apmid%2F30925872&rft.externalDocID=PMC6441174
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1472-6874&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1472-6874&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1472-6874&client=summon